Individual and cumulative effect of prostate cancer risk‐associated variants on clinicopathologic variables in 5,895 prostate cancer patients

Abstract

More than a dozen single nucleotide polymorphisms (SNPs) have been associated with prostate cancer (PCa) risk from genome‐wide association studies (GWAS). Their association with PCa aggressiveness and clinicopathologic variables is inconclusive.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 22, 2009
Source ID
10.1002/pros.20970

Entities

People

  • A. Karim Kader
  • Alan W. Partin
  • Angelo M. Demarzo
  • Bruce J Trock
  • Guifang Yan
  • Helen Fedor
  • Jianfeng Xu
  • Jielin Sun
  • Jonathan I. Epstein
  • Kathleen E. Wiley
  • Patrick C. Walsh
  • S. Lilly Zheng
  • Sarah D. Isaacs
  • Seong‐tae Kim
  • William B Isaacs

Organizations

  • National Cancer Institute
  • United States Department of Defense

Tags

Fields of Study

  • Biology

Readers

  • Molecular and genetic basis of cancer.
  • Oncology and Biomarker-Based Cancer Detection.
  • Prostate Cancer Biology.